Ophthotech reported $-30206000 in Operating Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Applied Genetic Technologies AGTC:US $ -14.49M 0.63M
Cytrx CYTR:US -1181210 98.64K
Insmed INSM:US $ -106255000 22.42M
Nektar Therapeutics NKTR:US $ -110.2M 0.81M
Novartis NOVN:VX 3.48B 1.06B
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M